International epidemiology of intracerebral hemorrhage

Current Atherosclerosis Reports

Volumn 14, Issue 4, 2012, Pages 300-306

  Ikram, M Arfan ^a   Wieberdink, Renske G ^a   Koudstaal, Peter J ^a  

^a ERASMUS MEDICAL CENTER   (Netherlands)

Author keywords

Epidemiology; Hypertension; Incidence; Intracerebral hemorrhage; Microbleeds; Risk factors

Indexed keywords

ACENOCOUMAROL; ACETYLSALICYLIC ACID; BLOOD CLOTTING FACTOR 7; BLOOD CLOTTING FACTOR 8; CHOLESTEROL; INTERLEUKIN 6; LIPID; NOTCH3 RECEPTOR; PHENPROCOUMON; TRIACYLGLYCEROL; WARFARIN;

ACE GENE; ALCOHOLISM; APOE GENE; APOH GENE; APP GENE; ARTICLE; BODY MASS; BRAIN HEMORRHAGE; CARDIOVASCULAR RISK; CR1 GENE; DIABETES MELLITUS; DISEASE ASSOCIATION; FACTOR VII GENE; FACTOR VIII GENE; GENE; GENETIC ASSOCIATION; GENETIC PREDISPOSITION; GENETIC RISK; HIGH RISK POPULATION; HUMAN; HYPERCHOLESTEROLEMIA; HYPERTENSION; IL 6 GENE; INCIDENCE; NOTCH3 GENE; NUCLEAR MAGNETIC RESONANCE IMAGING; PROGNOSIS; RISK ASSESSMENT; RISK BENEFIT ANALYSIS; SMOKING HABIT; VASCULAR AMYLOIDOSIS;

ALCOHOL DRINKING; ANTICOAGULANTS; CEREBRAL AMYLOID ANGIOPATHY; CEREBRAL HEMORRHAGE; DIABETES COMPLICATIONS; GENETIC PREDISPOSITION TO DISEASE; HUMANS; HYPERTENSION; INTRACRANIAL HEMORRHAGE, HYPERTENSIVE; MAGNETIC RESONANCE IMAGING; PROGNOSIS; RETINAL VESSELS; RISK FACTORS; SMOKING;

EID: 84865606549     PISSN: 15233804     EISSN: 15346242     Source Type: Journal    
DOI: 10.1007/s11883-012-0252-1     Document Type: Article

References (50)

1. Feigin VL. Stroke in developing countries: can the epidemic be stopped and outcomes improved? Lancet Neurol. 2007;6(2):94-7. (Pubitemid 46097530)
2. O'DonnellM, Yusuf S. Tackling the global burden of stroke: the need for large-scale international studies. LancetNeurol. 2009;8(4):306-7.
3. Abegunde DO, Mathers CD, Adam T, et al. The burden and costs of chronic diseases in low-income and middle-income countries. Lancet. 2007;370(9603):1929- 38. (Pubitemid 350192633)
4. Strong K, Mathers C, Bonita R. Preventing stroke: saving lives around the world. Lancet Neurol. 2007;6(2):182-7. (Pubitemid 46097543)
5. Feigin VL, Lawes CM, Bennett DA, et al. Worldwide stroke incidence and early case fatality reported in 56 population-based studies: a systematic review. Lancet Neurol. 2009;8(4):355-69.
6. Islam MS, Anderson CS, Hankey GJ, et al. Trends in incidence and outcome of stroke in Perth,Western Australia during 1989 to 2001: the Perth Community Stroke Study. Stroke. 2008;39(3):776-82. (Pubitemid 351619550)
7. Huhtakangas J, Tetri S, Juvela S, et al. Effect of increased warfarin use on warfarin-related cerebral hemorrhage: a longitudinal population-based study. Stroke. 2011;42(9):2431-5.
8. Benatru I, Rouaud O, Durier J, et al. Stable stroke incidence rates but improved case-fatality in Dijon, France, from 1985 to 2004. Stroke. 2006;37(7):1674-9. (Pubitemid 44297711)
9. Sivenius J, Tuomilehto J, Immonen-Raiha P, et al. Continuous 15-year decrease in incidence and mortality of stroke in Finland: the FINSTROKE study. Stroke. 2004;35(2):420-5. (Pubitemid 38174423)
10. Flaherty ML, Kissela B, Woo D, et al. The increasing incidence of anticoagulant-Associated intracerebral hemorrhage. Neurology. 2007;68(2):116-21. (Pubitemid 46071894)
11. Khellaf M, Quantin C, d'Athis P, et al. Age-period-cohort analysis of stroke incidence in Dijon from 1985 to 2005. Stroke. 2010;41 (12):2762-7.
12. Lovelock CE, Molyneux AJ, Rothwell PM Change in incidence and aetiology of intracerebral haemorrhage in Oxfordshire, UK, between 1981 and 2006: a population-based study. Lancet Neurol. 2007;6(6):487-93.
13. van Asch CJ, Luitse MJ, Rinkel GJ, et al. Incidence, case fatality, and functional outcome of intracerebral haemorrhage over time, according to age, sex, and ethnic origin: a systematic review and meta-Analysis. Lancet Neurol. 2010;9(2):167-76. A highly comprehensive review and meta-Analysis on frequency and prognosis of intracerebral hemorrhage. The various studies included together cover almos three decades of study periods.
14. Biffi A, Battey TW, Ayres AM, et al. Warfarin-related intraventricular hemorrhage: imaging and outcome. Neurology. 2011;77 (20):1840-6.
15. Ariesen MJ, Claus SP, Rinkel GJ, Algra A. Risk factors for intracerebral hemorrhage in the general population: a systematic review. Stroke. 2003;34(8):2060-5. (Pubitemid 36944806)
16. O'Donnell MJ, Xavier D, Liu L, et al. Risk factors for ischaemic and intracerebral haemorrhagic stroke in 22 countries (the INTERSTROKE study): a case-control study. Lancet. 2010;376 (9735):112-23. One of the largest pooled analysis investigating risk factors of intracerebral hemorrhage.
17. Zia E, Hedblad B, Pessah-Rasmussen H, et al. Blood pressure in relation to the incidence of cerebral infarction and intracerebral hemorrhage. Hypertensive hemorrhage: debated nomenclature is still relevant. Stroke. 2007;38(10):2681-5. (Pubitemid 47494004)
18. Leppala JM, Virtamo J, Fogelholm R, et al. Different risk factors for different stroke subtypes: association of blood pressure, cholesterol, and antioxidants. Stroke. 1999;30(12):2535-40.
19. Zhang Y, Tuomilehto J, Jousilahti P, et al. Lifestyle factors on the risks of ischemic and hemorrhagic stroke. Arch Intern Med. 2011;171(20):1811-8.
20. Andersen KK, Olsen TS, Dehlendorff C, Kammersgaard LP. Hemorrhagic and ischemic strokes compared: stroke severity, mortality, and risk factors. Stroke. 2009;40(6):2068-72.
21. Hankey GJ. Smoking and risk of stroke. J Cardiovasc Risk. 1999;6 (4):207-11. (Pubitemid 29421880)
22. Suh I, Jee SH, Kim HC, et al. Low serum cholesterol and haemorrhagic stroke in men: Korea Medical Insurance Corporation Study. Lancet. 2001;357(9260):922-5. (Pubitemid 32247281)
23. Suzuki K, Izumi M, Sakamoto T, Hayashi M Blood pressure and total cholesterol level are critical risks especially for hemorrhagic stroke in Akita, Japan. Cerebrovasc Dis. 2011;31(1):100-6.
24. Thrift AG, McNeil JJ, Forbes A, Donnan GA. Risk factors for cerebral hemorrhage in the era of well-controlled hypertension. Melbourne Risk Factor Study (MERFS) Group. Stroke. 1996;27 (11):2020-5. (Pubitemid 26372574)
25. Wieberdink RG, Poels MM, Vernooij MW, et al. Serum lipid levels and the risk of intracerebral hemorrhage: the Rotterdam Study. Arterioscler Thromb Vasc Biol. 2011;31(12):2982-9. One of the few recent studies to investigate lipid fractions in association with intracerebral hemorrhage as well as cerebral microbleeds. This paper provides insights into shared pathology of intracerebral hemorrhage and microbleeds with regard to lipids.
26. Sarwar N, Gao P, Seshasai SR, et al. Diabetes mellitus, fasting blood glucose concentration, and risk of vascular disease: a collaborative meta-Analysis of 102 prospective studies. Lancet. 2010;375(9733):2215-22.
27. Viswanathan A, Greenberg SM Cerebral amyloid angiopathy in the elderly. Ann Neurol. 2011;70(6):871-80. An in-depth overview of the current insights into cerebral amyloid angiopathy. A special focus is on imaging of cerebral amyloid angiopathy, including conventional MRI and amyloid imaging.
28. Knudsen KA, Rosand J, Karluk D, Greenberg SM Clinical diagnosis of cerebral amyloid angiopathy: validation of the Boston criteria. Neurology. 2001;56(4):537-9. (Pubitemid 32172884)
29. Neau JP, Couderq C, Ingrand P, et al. Intracranial hemorrhage and oral anticoagulant treatment. Cerebrovasc Dis. 2001;11(3):195-200. (Pubitemid 32304631)
30. Elkind MS, Sacco RL. Direct thrombin inhibition: a novel approach to stroke prevention in patients with atrial fibrillation. Stroke. 2004;35(6):1519-22. (Pubitemid 38697485)
31. He J, Whelton PK, Vu B, Klag MJ. Aspirin and risk of hemorrhagic stroke: a meta-Analysis of randomized controlled trials. JAMA. 1998;280(22):1930-5. (Pubitemid 28559811)
32. Rost NS, Greenberg SM, Rosand J. The genetic architecture of intracerebral hemorrhage. Stroke. 2008;39(7):2166-73.
33. Bellenguez C, Bevan S, Gschwendtner A, et al. Genome-wide association study identifies a variant in HDAC9 associated with large vessel ischemic stroke. Nat Genet. 2012;44(3):328-33. doi:10.1038/ng.1081
34. Hollingworth P, Harold D, Sims R, et al. Common variants at ABCA7, MS4A6A/MS4A4E, EPHA1, CD33 and CD2AP are associated with Alzheimer's disease. Nat Genet. 2011;43(5):429-35.
35. Biffi A, Shulman JM, Jagiella JM, et al. Genetic variation at CR1 increases risk of cerebral amyloid angiopathy. Neurology. 2012;78 (5):334-41.
36. Hu FB, Stampfer MJ, Colditz GA, et al. Physical activity and risk of stroke in women. JAMA. 2000;283(22):2961-7. (Pubitemid 30414508)
37. He K, Rimm EB, Merchant A, et al. Fish consumption and risk of stroke in men. JAMA. 2002;288(24):3130-6. (Pubitemid 36014130)
38. Lee M, Ovbiagele B. Reno-cerebrovascular disease: linking the nephron and neuron. Expert Rev Neurother. 2011;11(2):241-9.
39. Lee M, Saver JL, Chang KH, et al. Impact of microalbuminuria on incident stroke: a meta-Analysis. Stroke. 2010;41 (11):2625-31.
40. Biffi A, Cortellini L, Nearnberg CM, et al. Body mass index and etiology of intracerebral hemorrhage. Stroke. 2011;42 (9):2526-30.
41. Greenberg SM, Vernooij MW, Cordonnier C, et al. Cerebral microbleeds: a guide to detection and interpretation. Lancet Neurol. 2009;8(2):165-74. A reference paper for background, assessment, and clinical implications of cerebral microbleeds. Many studies have since been designed based on the recommendations provided in this paper.
42. Cordonnier C, van der Flier WM, Sluimer JD, et al. Prevalence and severity of microbleeds in a memory clinic setting. Neurology. 2006;66(9):1356-60. (Pubitemid 43739644)
43. Poels MM, Ikram MA, van der Lugt A, et al. Incidence of cerebral microbleeds in the general population: the Rotterdam Scan Study. Stroke. 2011;42(3):656-61.
44. Vernooij MW, van der Lugt A, Ikram MA, et al. Prevalence and risk factors of cerebral microbleeds: the Rotterdam Scan Study. Neurology. 2008;70(14):1208-14. (Pubitemid 351482572)
45. Cordonnier C, van der Flier WM Brain microbleeds and Alzheimer's disease: innocent observation or key player? Brain. 2011;134(Pt 2):335-44.
46. Baker ML, Hand PJ, Liew G, et al. Retinal microvascular signs may provide clues to the underlying vasculopathy in patients with deep intracerebral hemorrhage. Stroke. 2010;41 (4):618-23.
47. Wieberdink RG, Ho L, Ikram MK, et al. Age-related macular degeneration and the risk of stroke: the Rotterdam study. Stroke. 2011;42(8):2138-42.
48. Baker ML, Hand PJ, Wong TY, et al. Retinopathy and lobar intracerebral hemorrhage: insights into pathogenesis. Arch Neurol. 2010;67(10):1224-30.
49. Christensen MC, Broderick J, Vincent C, et al. Global differences in patient characteristics, case management and outcomes in intracerebral hemorrhage: the Factor Seven for Acute Hemorrhagic Stroke (FAST) trial. Cerebrovasc Dis. 2009;28(1):55-64.
50. Biffi A, Halpin A, Towfighi A, et al. Aspirin and recurrent intracerebral hemorrhage in cerebral amyloid angiopathy. Neurology. 2010;75(8):693-8.